Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer
2018 ◽
Vol 268
(2)
◽
pp. 215-222
◽
2014 ◽
Vol 113
(1)
◽
pp. 41-46
◽
2018 ◽
Vol 210
(5)
◽
pp. 1059-1065
◽
2011 ◽
Vol 81
(2)
◽
pp. S335
2010 ◽
Vol 78
(3)
◽
pp. S320
2013 ◽
Vol 2
(4)
◽
pp. 413-425
◽